共 221 条
[1]
Grisold A(2017)Chemotherapy-induced peripheral neuropathy: a current review Ann Neurol 81 772-781
[2]
Grisold W(2013)The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings Ann Oncol 24 454-462
[3]
Windebank AJ(2013)Chemotherapy-induced peripheral neurotoxicity: a critical analysis CA Cancer J Clin 63 419-437
[4]
Cavaletti G(2017)Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) Qual Life Res 26 2999-3010
[5]
Cornblath DR(2012)The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA Support Care Cancer 20 625-632
[6]
Merkies IS(2018)Impact of chemotherapy-induced neurotoxicities on adult cancer survivors’ symptom burden and quality of life J Cancer Surviv 12 234-245
[7]
Postma TJ(2017)The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis Eur J Cancer Care 26 e12443-2269
[8]
Rossi E(2014)Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review Support Care Cancer 22 2261-133
[9]
Frigeni B(2018)Risk factors for the development of paclitaxel-induced neuropathy in breast cancer patients J Peripher Nerv Syst 23 129-282
[10]
Alberti P(2005)Symptom clusters: concept analysis and clinical implications for cancer nursing Cancer Nurs 28 270-858